Abstract
Orthomolecular therapy has had much support and much opposition, and yet there remain a number of professionals and parents who continue the quest for its effective application in the amelioration of psychiatric disorders. The popular press has again been the forum for heated debate between those who debunk its possibilities and those who attest to its operative use. Because the parents of mentally retarded and mentally ill children are particularly vulnerable to the raising or dashing of their hopes against claims being made either way, this paper provides an overview and history of orthomolecular therapy, its application to both mental illness and mental retardation, as well as toxicity considerations relative to megavitamin treatment, in the hope that such information will provide mental health professionals with concise an swers to the challenging questions currently being asked by their patients.
Similar content being viewed by others
References
Olson RE, Broguist HP, Chichester CO, Darby WJ, Kolbye AC, & Stalvey RM:Nutrition reviews present knowledge in nutrition, (5th Edition). Washington, DC: The Nutrition Foundation, Inc, 1984.
Carpenter KJ:The History of Scurvy and Vitamin C. New York, Cambridge University Press, 1986.
Hillman RE: Megavitamin responsive aminoacidopathies.Pediatric Clinics of North America, 23(3), 557–567, 1976.
Fernhoff P, Lubitz D, Danner D, Dembure P, Schwartz H, Hillman R, Bier D, & Elsas L: Thiamine response in maple syrup urine disease.Pediatric Research, 19, 1011–1016, 1985.
Scriver C, Clow C, & George H: So-called thiamine-responsive maple syrup urine disease: 15-year follow-up of the original patient.The Journal of Pediatrics, 107(5), 763–765, 1985.
Hathcock J: Toxicity of vitamins for vitamin nutrition information service (VNIS)Vitamin Issues, 1, 1–6, 1985.
Food and Nutrition Board. National Research Council—National Academy of Sciences: Recommended dietary allowances: Scientific issues and process for the future.Journal of Nutrition, 116, 482–486, 1986.
Pauling L: Orthomolecular psychiatry.Science, 160, 265–271, 1968.
Kunin RA: Orthomolecular Psychiatry. In: R.P. Huemer (Ed.):The roots of molecular medicine. New York: W.H. Freeman Company, 1986.
Hoffer A, Osmond H, Callback J, & Kahan R: Treatment of schizophrenics with nicotine acid and nicotinamide.J Clin Exper Psychopath. 18, 131–158, 1957.
Hoffer A & Osmond H: Nicotinamide adenine dinucleotide (NAD) as a treatment for schizophrenia.Journal of Psychopharmacology, 1, 79–94, 1966.
Hoffer A: Orthomolecular therapy.Psychiatric Opinion, 10, 6, 1973.
Mosher LR: Nicotinic acid side affects and toxicity: A review:American Journal of Psychiatry, 126, 124–130, 1979.
American Psychiatric Association. Task Force on Orthomolecular Therapy.Psychiatric News, July, 1973.
Canadian Schizophrenic Foundation. Megavitamins in therapy.Reply to the American Psychiatric Association Task Force Report on Megavitamins and Orthomolecular Psychiatry. Regina, Saskatchewan, 1976.
Jukes TH: Megavitamin Therapy.Journal of the American Medical Association, 233, 550–551, 1975.
White P: Megavitamin this and megavitamin that.Journal of the American Medical Association, 233, 538–539, 1975.
Adler S: Behavior management: A nutritional approach to the behaviorally disordered and learning disabled child.Journal of Learning Disabilities, 11, 651–656, 1978.
Cott A: Orthomolecular approach to the treatment of learning disabilities.Schizophrenia, 3, 95–105, 1971.
Cott A: Megavitamins: The orthomolecular approach to behavioral disorders and learning disabilities.Academic Therapy, 7, 245–258, 1972.
Cott A: Treatment of learning disabilities.Journal of Orthomolecular Psychiatry, 3, 343–355, 1974.
Rimland B, Callaway E, & Dreyfus P: The effects of high doses of vitamin B6 on autistic children: A double-blind crossover study.American Journal of Psychiatry, 4(135), 472–475, 1978.
Rimland B: High dosage levels of certain vitamins in the treatment of children with severe mental disorders. In D. Hawkins and L. Pauling (Eds.),Orthomolecular psychiatry, New York: Freeman W.H., 1973
Rimland B: An orthomolecular study of psychotic children.Orthomolecular psychiatry, 3, 371–377, 1974.
Schmid F:Cytobiologishe revue, 1, 25–32, 1978.
Turkel H:New hope for the mentally retarded, New York: Vantage Press, 1972.
Turkel H: Medical amelioration of Down's syndrome incorporating the orthomolecular approach.The Journal of Orthomolecular Psychiatry, 4, 2. 102–115. 1975.
Turkel H: A treatment for mongolism stymied by the FDA.Prevention. 61–79, 1979.
Wunderlich R: Treatment of the hyperactive child.Academic Therapy, 8, 375–390, 1973.
Arnold L, Christopher J, Heustis R, & Smeltzer D: Megavitamins for minimal brain dysfunction: A placebo controlled study.Journal of the American Medical Association, 240, 2642–2643, 1978.
Bumbalo T, Morelevica H, & Bernas D: Treatment of Down's syndrome with the “U” series of drugs.Journal of the American Medical Association, 198, 125–131, 1964.
Kershner J & Gerkin R: A pilot study of a high-protein and high-vitamin, low carbohydrate, sugar-free diet with learning disabled children.Special education monograph, Toronto: Ontario Institute for Studies in Education, 1976.
Morgan DG: An overview of research at Walden House. Paper presented at Atlanta Regional Conference of the National Society for Autistic Children: Atlanta. GA. 1976.
Kershner J & Hawke W:Nutrition, 109, 819–826, 1979.
Harrell R, Capp R, Davis D, Peerless J, & Ravitz L: Can nutritional supplements help mentally retarded children? An exploratory study.Proc Nat'l Acad Sci USA, 78, 1, 574–578, 1981.
Williams RJ: Biochemical individuality: The basis for the genetotrophic concept. Austin: University of Texas Press, 1956.
Feingold BF: Hyperkinesis and learning disabilities linked to artificial food flavors and colors.American Journal of Nursing, 75, 5, 797–803, 1975.
Feingold BF: Hyperkinesis and learning disabilities linked to the ingestion of artificial food colors and flavors.Journal of Learning Disabilities, 9, 551–559, 1976.
Conners C, Goyette C, Southwick D, Lees J & Andrulonis P: Food additives and hyperkinesis: A controlled double-blind experiment.Pediatrics, 58, 154–166, 1976.
Snyder S, Baraban J & Worley P: Second messengers in brain function and psychiatry.Strecker Monograph Series, Number XXIII, 1986.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Menolascino, F.J., Donaldson, J.Y., Gallagher, T.F. et al. Orthomolecular therapy: Its history and applicability to psychiatric disorders. Child Psych Hum Dev 18, 133–150 (1988). https://doi.org/10.1007/BF00709727
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00709727